Age at diagnosis, obesity, smoking, and molecular subtypes in muscle-invasive bladder cancer

被引:20
|
作者
Sun, Xuezheng [1 ]
Hoadley, Katherine A. [2 ,3 ]
Kim, William Y. [2 ,3 ,4 ,5 ]
Furberg, Helena [6 ]
Olshan, Andrew F. [1 ,2 ]
Troester, Melissa A. [1 ,2 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Suite 32,CVS Plaza,137 East Franklin St,CB 8050, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Genet, Chapel Hill, NC USA
[4] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC USA
[5] Univ N Carolina, Dept Urol, Chapel Hill, NC USA
[6] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
Muscle-invasive bladder cancer; Molecular subtype; Age; Obesity; Smoking; LUMINAL SUBTYPES; BASAL; RISK; ASSOCIATION; PROGNOSIS; SURVIVAL; PATTERNS; STAGE; GRADE;
D O I
10.1007/s10552-017-0885-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Heterogeneity of muscle-invasive bladder cancer (MIBC) has been characterized using whole-genome mRNA expression data, showing distinct molecular and clinicopathological characteristics by subtypes. However, associations between risk factors and molecular subtypes have not been reported. Methods Four previously published schemes were used to categorize molecular subtypes in 372 MIBC patients from the Cancer Genome Atlas (TCGA). Data on gene expression (RNA-seq), demographic, and clinicopathological characteristics were retrieved through TCGA data portal. Polytomous logistic regression was used to estimate the associations of subtypes by different schemes with age at diagnosis, obesity, and smoking. Results While some quantitative variation was evident, distinct molecular subtype schemes showed considerable consistency in the association with the risk factors. Generally, compared to patients with luminal-like tumors, patients with basal-like subtypes were more likely to be older (OR75 + yrs vs. < 60 years range = 1.32-2.89), obese (ORobese vs. normal range = 1.30-3.05), and to start smoking at early age (OR < 18 years vs. 25+ years range = 1.11-4.57). Conclusions Different molecular subtypes of MIBC may have distinct risk profiles. Large population-based studies with detailed information on bladder cancer risk factors are needed to further define etiologic heterogeneity for bladder cancer.
引用
收藏
页码:539 / 544
页数:6
相关论文
共 50 条
  • [41] INTRATUMORAL HETEROGENEITY OF MOLECULAR SUBTYPES IN MUSCLE-INVASIVE BLADDER CANCER - AN EXTENSIVE MULTI-REGIONAL IMMUNOHISTOCHEMICAL ANALYSIS
    Schallenberg, Simon
    Dragomir, Mihnea
    Anders, Philipp
    Ebner, Benedikt
    Volz, Yannic
    Eismann, Lennert
    Rodler, Severin
    Casuscelli, Jozefina
    Buchner, Alexander
    Klauschen, Frederick
    Stief, Christian
    Horst, David
    Schulz, Gerald
    JOURNAL OF UROLOGY, 2023, 209 : E729 - E729
  • [42] Centrosome Protein 78 Is Overexpressed in Muscle-Invasive Bladder Cancer and Is Associated with Tumor Molecular Subtypes and Mutation Signatures
    Huang, Xiaoli
    Yan, Yang
    Wei, Rong
    Liu, Hu
    Zhu, Xingchen
    Bi, Dexi
    Wei, Qing
    Yao, Xudong
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [43] Bladder sparing options for muscle-invasive bladder cancer
    Laukhtina, Ekaterina
    Moschini, Marco
    Teoh, Jeremy Yuen-Chun
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2024, 34 (06) : 471 - 476
  • [44] Bladder preserving strategies for muscle-invasive bladder cancer
    Merseburger, Axel S.
    Matuschek, Ira
    Kuczyk, Markus A.
    CURRENT OPINION IN UROLOGY, 2008, 18 (05) : 513 - 518
  • [45] Defining Molecular Features Of Local Recurrence In Muscle-Invasive Bladder Cancer
    Ballas, L. K.
    Xu, Y.
    Mouw, K. W.
    Aron, M.
    Daneshmand, S.
    Manojlvic, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E883 - E884
  • [46] GENE REGULATORY NETWORKS ANALYSIS FOR SUBTYPES OF MUSCLE-INVASIVE BLADDER CANCER BASED ON PATHWAY
    Chen, Qingyuan
    Jiang, Meng
    Zeng, Yuanqi
    Zhang, Yongqing
    Gao, Dongrui
    2019 16TH INTERNATIONAL COMPUTER CONFERENCE ON WAVELET ACTIVE MEDIA TECHNOLOGY AND INFORMATION PROCESSING (ICWAMTIP), 2019, : 92 - 95
  • [47] The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization
    Mau, Brian
    Johnson, Burles
    Hansel, Donna E.
    McConkey, David J.
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (01) : 1 - 11
  • [48] Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer
    Amisha Singh
    Appledene S. Osbourne
    Vadim S. Koshkin
    Current Treatment Options in Oncology, 2023, 24 (9) : 1213 - 1230
  • [49] Managing muscle-invasive bladder cancer in the elderly
    Weizer, Alon Z.
    Palella, Gaetano V.
    Montgomery, Jeffrey S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (06) : 903 - 915
  • [50] Guideline of guidelines: Muscle-invasive bladder cancer
    Omorphos, Nicolas Pavlos
    Piedad, John Carlo Pansaon
    Vasdev, Nikhil
    TURKISH JOURNAL OF UROLOGY, 2021, 47 : S71 - S78